Screener
Amphastar Pharmaceuticals AMPH Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Net revenues | $183,903 | $174,414 | $355,074 | $344,942 |
| Cost of revenues | 90,433 | 87,924 | 191,282 | 173,201 |
| Gross profit | 93,470 | 86,490 | 163,792 | 171,741 |
| Operating expenses: | ||||
| Selling, distribution, and marketing | 13,335 | 10,235 | 25,262 | 22,101 |
| General and administrative | 18,242 | 13,991 | 36,270 | 29,987 |
| Research and development | 22,164 | 20,080 | 48,901 | 40,176 |
| Total operating expenses | 53,741 | 44,306 | 110,433 | 92,264 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's gross profit?
- Amphastar Pharmaceuticals (AMPH) reported gross profit of $93.47M in Q2 2026.
- How has Amphastar Pharmaceuticals's gross profit changed year-over-year?
- Amphastar Pharmaceuticals's gross profit increased by 8.1% year-over-year, from $86.49M to $93.47M.
- What is the long-term trend for Amphastar Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's gross profit has grown at a 15.5% compound annual growth rate (CAGR), from $199.74M to $356.06M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Amphastar Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude